Results 1 to 10 of about 45,130 (259)

Adherence to the antirheumatic drugs: a systematic review and meta-analysis [PDF]

Frontiers in Medicine
IntroductionThis systematic review and meta-analysis aimed to analyze the adherence rate for conventional and biological disease-modifying antirheumatic drugs (DMARDs) utilizing different assessment measures.MethodA systematic literature search was ...
Nilay Aksoy, Nur Ozturk, Tamas Agh, Tamas Agh, Przemyslaw Kardas   +4 more
doaj   +2 more sources

Comparative effectiveness of disease-modifying antirheumatic drugs for patients with cardiac sarcoidosis. [PDF]

Rheumatology (Oxford)
Brooks L, Kivlin W, Mohananey D, Sabchyshyn V, Putman M.   +4 more
europepmc   +3 more sources

Disease-modifying antirheumatic drugs – Old and new: A brief overview

Clinical Dermatology Review, 2019
Rheumatological disorders comprise a vast subset of conditions with differing manifestations but overlap in pathogenesis. Disease-modifying antirheumatic drugs (DMARDs) are a diverse group of medications which aim at the various pathogenic factors ...
Vidya Divakar Baliga, Raghuveer S Prabhu
doaj   +2 more sources

Efficacy and safety of non-conventional synthetic disease-modifying antirheumatic drugs in early active rheumatoid arthritis: a network meta-analysis. [PDF]

BMC Rheumatol
Xu H, Li C, Ding R, Zhan Y, Liu H, Liang X, Niu Y, Luo Y, Hu Z, He J, Chen L, Wang T, Fang Y.   +12 more
europepmc   +2 more sources

Complications of invasive oral procedures in patients with immune-mediated inflammatory disorders treated with biological and conventional disease-modifying antirheumatic drugs or glucocorticoids: a scoping review of the literature. [PDF]

BMC Oral Health
Radoi L, Kadri M, Gosset M.
europepmc   +3 more sources

Repurposing haloperidol for the treatment of rheumatoid arthritis: an integrative approach using data mining techniques

Therapeutic Advances in Musculoskeletal Disease, 2021
Introduction: Treatment of rheumatoid arthritis (RA) has advanced with the introduction of biological disease-modifying antirheumatic drugs. However, more than 20% of patients with RA still have moderate or severe disease activity.
Chihiro Nakagawa, Satoshi Yokoyama, Kouichi Hosomi, Mitsutaka Takada   +3 more
doaj   +1 more source

COVID-19 Therapy: the Role of Antirheumatic Drugs

Антибиотики и Химиотерапия, 2021
Currently, the close attention of the medical and international community is still riveted on the novel coronavirus infection, which caused the pandemic in 2020.
M. A. Litvinova, N. V. Muravyeva, B. S. Belov   +2 more
doaj   +1 more source

Recent advances: rheumatology [PDF]

, 2000
No abstract ...
Madhok, R., Kerr, H., Capell, H.A.
core   +6 more sources

Antirheumatic drugs and COVID-19: frustrations and hopes

Медицинский совет, 2021
In accordance with current views on the pathogenesis of the new coronavirus infection, some antirheumatic drugs are considered as therapeutic agents for suppressing the hyperinflammatory response in severe COVID-19. The review presents literature data on
E. S. Aronova, B. S. Belov
doaj   +1 more source

Biologics May Prevent Cardiovascular Events in Rheumatoid Arthritis by Inhibiting Coronary Plaque Formation and Stabilizing High-Risk Lesions. [PDF]

, 2020
ObjectiveTo evaluate whether biologic disease-modifying antirheumatic drugs (DMARDs) decrease cardiovascular disease (CVD) risk in rheumatoid arthritis (RA) and whether biologic DMARDs might have a beneficial effect on coronary plaque formation or ...
Budoff, Matthew J, Hernandez, Elizabeth, Karpouzas, George A, Ormseth, Sarah R   +3 more
core   +1 more source